Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 581 to 590

ROXITHROMYCIN AN roxithromycin 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMOXYCLAV GH 500/125 amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
DORZOLAMIDE/TIMOLOL SANDOZ 20/5 dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drops solution bottle Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIDAZOLAM SANDOZ midazolam 5mg/5mL injection ampoule Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIDAZOLAM SANDOZ midazolam 5mg/1mL injection ampoule Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIDAZOLAM SANDOZ midazolam 15mg/3mL injection ampoule Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
BISOPROLOL GH bisoprolol fumarate 2.5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
BISOPROLOL GH bisoprolol fumarate 5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
BISOPROLOL GH bisoprolol fumarate 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd
ROPIVACAINE SANDOZ ropivacaine hydrochloride (as monohydrate) 75mg/10mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 55
Page 56
Page 57
Page 58
Current page 59
Page 60
Page 61
Page 62
Page 63
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.